Friday, November 18, 2011
Print Current Session:
|
|
Friday
SESSION 24:
NEW TECHNIQUES AND NEW ENDOVASCULAR TECHNOLOGY (5-MINUTE TALKS)
Moderators:Ronald M. Fairman, MD / Matt M. Thompson, MD
|
|
SESSION 24 SCHEDULE | |
PROGRAM C (SESSIONS 24 - 27) - LOCATION: GRAND BALLROOM EAST, 3RD FLOOR | |
6:40 AM - 6:45 AM | Femoral Artery Exposure Complications Can Be Reduced By Using An Ultrasonic Coagulation Device (Focus From Ethicon) Rather Than Bovie Cautery |
Presenter(s):Patrick E. Muck, MD, FACS | |
6:46 AM - 6:51 AM | A New Flow Reversal Device For CAS Via A Cervical Approach Which Requires A Common Carotid Exposure |
Presenter(s):Christopher J. Kwolek, MD | |
6:52 AM - 6:57 AM | Radiofrequency Renal Artery Neurolysis For Treatment Of Refractory Hypertension: Technique And Results |
Presenter(s):Mark H. Wholey, MD | |
6:58 AM - 7:03 AM | Advantages Of A Robotic Guidance System For Catheter Steerage In The Performance Of Fenestrated And Branched Endografting (The Hansen System) |
Presenter(s):Nicholas J.W. Cheshire, MD | |
7:04 AM - 7:09 AM | Acute Interventions For Stroke: Will Temporary And Permanent Stents Make A Difference: The Temporary Bypass And Clot Removal Concept |
Presenter(s):L. Nelson Hopkins, MD | |
7:10 AM - 7:15 AM | Development Of Bioresorbable Scaffold Platforms For The Peripheral Vasculature: Can The Excellent Coronary Results Of The ABSORB TRIAL With Everolimus Polylactide Be Duplicated In Peripheral Arteries |
Presenter(s):Lewis B. Schwartz, MD | |
7:16 AM - 7:21 AM | Bioabsorbable Polymers And Biodegradable Stents In Peripheral Arteries: Where Are We Going |
Presenter(s):Ron Waksman, MD | |
7:22 AM - 7:27 AM | Long-Term (5-Year) Results Of The INSTEAD Trial Support The Advantages Of Early Endograft Treatment Of Uncomplicated Type B Aortic Dissections |
Presenter(s):Christoph A. Nienaber, MD, PhD | |
7:28 AM - 7:35 AM | Panel Discussion |
END OF SESSION 24 | |
previous | next |